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Great efforts have been made to introduce growth factors (GFs) onto 2D/3D constructs in order to control
cell behavior. Platelet lysate (PL) presents itself as a cost-effective source of multiple GFs and other
proteins. The instruction given by a construct-PL combination will depend on how its instructive cues are
presented to the cells. The content, stability and conformation of the GFs affect their instruction. Stra-
tegies for a controlled incorporation of PL are needed. Herein, PL was incorporated into nanocoatings by
layer-by-layer assembling with polysaccharides presenting different sulfation degrees (SD) and charges.
Heparin and several marine polysaccharides were tested to evaluate their PL and GF incorporation
capability. The consequent effects of those multilayers on human adipose derived stem cells (hASCs)
were assessed in short-term cultures. Both nature of the polysaccharide and SD were important prop-
erties that inﬂuenced the adsorption of PL, vascular endothelial growth factor (VEGF), ﬁbroblast growth
factor b (FGFb) and platelet derived growth factor (PDGF). The sulfated polysaccharides-PL multilayers
showed to be efﬁcient in the promotion of morphological changes, serum-free adhesion and proliferation
of high passage hASCs (P > 5). These biomimetic multilayers promise to be versatile platforms to
fabricate instructive devices allowing a tunable incorporation of PL.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
The design of cell instructive surfaces is of major interest in the
ﬁeld of tissue engineering and regenerative medicine. Cell behavior
is dictated by the interactions occurring between cell surface
macromolecules, e.g. transmembrane proteins, glycolipids, glyco-
proteins and carbohydrates with the extracellular environment
[1e4]. Cells are embedded in extracellular matrix (ECM), which is
rich in glycosaminoglycans, proteoglycans, water and growth fac-
tors (GFs), and confers mechanical support and anchorage points.
GFs are cytokines present either in soluble form or non-covalently
bound to ECM polysaccharides presenting various sulfation de-
grees. GFs bind to cell tyrosine kinase receptors triggering's Research Group, Dept. of
ecnologia, Zona Industrial da
þ351 253510900; fax: þ351
.intracellular events, making them very attractive molecules for cell
behavior manipulation [5]. Cell behavior is affected by the con-
centration of GFs, as well as, by the presence or absence of their
conjugations with sulfated polysaccharides [6]. GFs have a short
half-life and so, strategies for their stabilization and exposure to
cells at adequate doses, to trigger the adequate cell responses, are
very important for many therapeutic applications [7,8]. Several
methodologies for the introduction of one or two different re-
combinant GFs (rGFs) have been used: covalent binding [9,10],
absorption [10], biotinylated heparin-avidin bonding [11], layer-by-
layer (LbL) assembling [12], GF absorption onto pre-built LbL mul-
tilayers [13,14], and electrostatic binding with heparin [15,16].
However, more translational developments in this area have been
hindered by the high cost of rGFs, and difﬁculties to introduce
simultaneously several GFs.
Platelets arise as a cost-effective autologous source of multiple
GFs and other bioactive proteins e Scheme 1a. Among them, some
have a proven ability to improve, for instance, adhesion, mito-
genesis and cell differentiation [17e19]. The instructive potential of
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Scheme 1. Main steps for the preparation of PL/Polysaccharides Layer-by-Layer assembled nanocoatings. a) Platelet isolation from human blood as Platelet-Rich-Plasma (PRP) and
examples of bioactive proteins than can be found in the enriched protein cocktail. b) PL preparation: PRP activation by platelet disruption induced by thermal cycles for the release
of the inner content. c) Layer-by-Layer deposition combining PL with several PEs which respective functional groups and content are indicated.
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with the GF content and also displays variability associated with
the donor [20e22]. Platelet's derived GFs have been successfully
included onto surfaces employing adsorption [23,24] and antigen
speciﬁc GF recruitment from platelet lysate (PL) [25]. Sole absorp-
tion of GFs only allows for a short-term control over cells since,
typically, they are quickly released. Covalent binding of a GF allows
a more stable presentation to the cells. However, its activity may be
compromised by changes in the GFs conformation, masking the
active sites, or by GF-receptor complexes cell internalization inhi-
bition [26].
LbL is a simple and versatile technology that has been employed
in the development of a large variety of biomedical devices [27,28].
It is often based on a simple alternated deposition of negatively and
positively charged polyelectrolytes (PEs). LbL can be performed in
protein-mild conditions on virtually any substrate, ranging from
nanoparticles to 3D scaffolds and hydrogels [27,28]. There are re-
ports on the beneﬁcial use of one or two rGFs in LbL approaches
[12,29,30].
We believe that it would be advantageous to include multiple
GFs from human sources as structural components of the multi-
layers, increasing both the complexity of the structures and the
similarity with the ECM. We propose the use of LbL assembling for
the development of multilayers nanocoatings containing PL in their
structural composition, in which cell instructive cues can be pre-
served. PL was combined with several polyelectrolytes (PEs) pre-
senting different SD (from 0 to 3 sulfate groups per sugar unit),
different charges, functional groups conformation, and compared
to the gold standard for protein stabilizatione heparin. Heparin is a
highly sulfated polysaccharide that has been widely used to stabi-
lize and attract rGFs [15,16,31,32] and has been inspiring the syn-
thesis of new polymeric matrices with heparin-analog ending
groups [33]. PEs were assessed for their capability to adsorb PL,
including the following speciﬁc GFs: VEGF, PDGF and FGFb. The role
of the PE used and the bioactivity of those multilayers were eval-
uated by assessing its mitogenic, morphological and phenotypic
effects on human adipose derived stem cells (hASCs).2. Materials and methods
2.1. Materials
Medium molecular weight chitosan (Chi), with a degree of deacetylation of 80%
(Sigma Aldrich, MKBB0566), was puriﬁed by a re-precipitation method. Brieﬂy, Chi
powder was ﬁrst dissolved in 2% (v/v) acetic acid solution at a 1% (w/v) concen-
tration. The mixture was maintained under stirring overnight at room temperature.
The impurities were removed by four ﬁltration cycles. Then, Chi was precipitated by
addition of 1 M NaOH while stirring. Final steps consisted of washing Chi with
distilled water until reaching a neutral pH and of dehydration by washing with
ethanolewater mixtures with increasing ethanol content (20e100% v/v). Chi was
freeze-dried for 3 days and grinded. k- (SigmaeAldrich, 22048), i- (Fluka, 22045), l-
carrageenan (Car; SigmaeAldrich, 22049), sodium heparin (Hep; SigmaeAldrich,
H3149), sodium alginate (Alg; Sigma Aldrich, 250 cP), and poly(ethyleneimine) so-
lution (PEI; SigmaeAldrich, P3143) were used as received.
2.2. Materials preparation
2.2.1. Preparation of platelet lysate
Platelet concentrates were obtained from different platelet collections per-
formed at Instituto Portugue^s do Sangue (IPS, Porto, Portugal), under a previously
established cooperation protocol. The components were obtained using either the
Trima Accel® Automated Blood Collection System. All the platelet products were
biologically qualiﬁed according to the Portuguese legislation. The platelet count was
performed at the IPS using the COULTER® LH 750 Hematology Analyzer and the
sample volume adjusted to 1 million platelet.mL1. The collected samples were
subject to three repeated temperature cycles (frozenwith liquid nitrogen at196 C
and heated at 37 C) and frozen at 20 C until further use. The remaining platelets
were eliminated by centrifugation at 1400 g for 10 min. Aliquots of platelet lysate
(PL) were stored at 20 C until ﬁnal use.
2.2.2. Polyelectrolytes solutions
k-,i-, l-Car, Hep and Alg were prepared in 1 M Tris HCL 40 nM NaCl pH 7.4 with a
concentration of 0.5 mg.mL1. Chi was dissolved in sodium acetate buffer with a
concentration of 0.5 mgmL1. All the solutions were gently stirred overnight. PL was
10-fold diluted with Tris HCL buffer or in 1 M sodium acetate 40 mM NaCl pH 6 when
to be combined with Chi.
2.2.3. QCM-D monitoring
A Q-Sense E4 quartz crystal microbalance (QCM-D, Q-Sense AB, Sweden) with
dissipation was used for in situ monitoring the deposition of PE/PL bilayers at the
surface of 100 nm gold-coated crystals. The crystals were first cleaned in an ultra-
sound bath at 30 C, and immersed successively in acetone, ethanol, and iso-
propanol. All crystals were initially modiﬁed with PEI to confer an initial positive
charge. A 0.5% w/v PEI solution (Mw 750,000, SigmaeAldrich) was pumped for
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the combination Chi/PL was Alg.
The different polysaccharides were assembled with PL at pH 7.4, or 6 in the case
of Chi, in the respective buffer solutions above mentioned. Brieﬂy, AT cut quartz
crystals were excited at multiple overtones (1, 3, 5, 7, 11, and 13), which correspond
to 5, 15, 25, 35, 45, 55 and 65 MHz, respectively. The PEs solutions (0.5 mg.ml1)
were pumped with a constant ﬂow rate of 50 mL min1, for 10 min at room tem-
perature. As intermediate step, the respective buffer solutions were pumped during
10 min to rinse the crystals.
2.2.4. Coatings preparation in 48-well plates
48-well plates were modiﬁed with 0.5 mL of 0.5% (w/v) PEI solution to confer a
positive surface charge. Then, the solution was removed and the wells were
extensively rinsed with distilled water in order to remove the unbound PEI. The LbL
was started by the adsorption of the negative PE. In the case of Chi, an Alg layer was
ﬁrst adsorbed. The adsorption times and volumes used were: 4 min and 0.5 mL for
the polysaccharides solutions; 0.5 mL and 10 min for the PL solution; intermediate
rising steps 2 for 30 s using the respective buffers. The sequence was repeated 6
times. The well plates were let to air-dry overnight and then sterilized using a UV
light for 40 min.
2.2.5. Protein adsorption
6-well plates were modiﬁed with PEI and the PEs, as described before. Two
milliliters of PL 10% (v/v) or PL 100% (v/v), pH 6 and pH 7.4, were added to each well
and let to adsorb for 30 min. The volume was removed and stored at 20 C for
further quantiﬁcation. Each well was rinsed with 2 mL of the respective buffer,
which was then stored for further protein quantiﬁcation.
The total protein was quantiﬁed in the following solutions: initial PL, PL before
and after adsorption, and rising solutions. The measurements were performed using
a NanoDrop 1000 Spectrophotometer (Thermo Scientiﬁc). The absorbance of 2 mL
volume of solution was measured at the wavelength 280 nm (n ¼ 6). The amount of
PDGF (PL10%), FGFb (PL100%) and VEGF (PL100%) was quantiﬁed using ELISA kits
following the assay protocol provided with the kit. Optical density was read at
450 nm (n¼ 6) on amulti-well microplate reader (Synergy HT, Bio-Tek Instruments).
2.3. Cell behavior assessment
2.3.1. hASCs isolation
Human subcutaneous adipose tissue samples were obtained from lipoaspiration
procedures performed on women with ages between 35 and 50 years under a
protocol previously established with the Department of Plastic Surgery of Hospital
da Prelada in Porto, Portugal. All the samples were processed within 24 h after the
lipoaspiration procedure. hASCs were enzymatically isolated from subcutaneous
adipose tissue as previously described [34]. Brieﬂy, the lipoaspirate samples were
ﬁrstly washed with a solution of PBS and 10% Antibiotic/Antimycotic. Liposuction
tissue was digested with 0.2% Collagenase Type II solution for 90 min with inter-
mittent shaking, at 37 C. The digested tissue was ﬁltered using a 100 mm ﬁlter mesh
(SigmaeAldrich, Germany). The ﬂoating adipocytes were separated from the pre-
cipitation stromal fraction by centrifugation at 1250 rpm for 10 min. The cell pellet
was re-suspended in lysis buffer for 10 min to disrupt the erythrocytes. After a
centrifugation at 800 rpm for 10 min, cells were again re-suspended and placed in
culture ﬂasks with Minimum Essential a Medium (SigmaeAldrich) supplemented
with sodium bicarbonate, antibiotic/antimycotic and 10% of Fetal Bovine Serum (Life
Technologies). Cells were cultured until conﬂuence at 37 C, 5% CO2 incubator,
changing the medium every 2 days.
2.3.2. Cell seeding
To proceed with the cell seeding, expanded cells were harvested by trypsini-
zation and ﬁltered with a 100 mm cell strainer to remove possible cell aggregates.
Two cellular suspensions with a density of 1  104 cells.mL1 were prepared in
minimum essential amedium supplemented with 0% or 10% FBS. A volume of 500 ml
of cell suspensionwas dripped into eachwell. Well-plates were incubated for 20 h or
4 days for the assessment of cell adhesion, morphology, proliferation, ALP activity/
cell and phenotype, without changing themedium. hASCs from two different donors
and between passage 5 and 6 were used.
2.3.3. Cell morphology
After 20 h in culture, samples were gently rinsed twice with sterile PBS and then
fixed with formalin 2.5% (v/v) during 20 min. Cells were permeabilized with 0.5 mL
of Triton 0.2% (v/v) in PBS during 2 min and then rinsed with PBS. Samples were
incubated in the dark with 100 mL of (1:100) Phalloidin-TRITC (SigmaeAldrich) so-
lution for 30min and thenwashedwith PBS. For cell nuclei staining, well plates were
incubated in the dark for 5 min with 100 mL 4,6-diamino-2-phenyindole dilactate
(DAPI, SigmaeAldrich) diluted 1:1000 in PBS. Samples were observed using an
inverted Axio Observer Fluorescence Inverted Microscope (Zeiss).
2.3.4. Cell morphology analysis
Cell length, width and mean area were measured using the Image J software
version 1.48. Cell length was considered the longest distance between the tips of theﬁlopodias (200 < n < 300 cells from 8 images). The width was measured on the cell
nucleus position and usually in an angle approximately right to the cell length
(200 < n < 400 cells from 8 images). Cell area was calculated dividing the total
number of nucleus by the total area covered by the same cells (n ¼ 8). Cell aspect
ratio was calculated by diving cell length per cell width.2.3.5. dsDNA quantiﬁcation
In order to quantify cell attachment and proliferation after 20 h and 4 days in
culture, dsDNA was quantiﬁed using the Quant-iT™ PicoGreen® dsDNA assay kit
(Molecular Probes/Invitrogen) that allows the measurement of the ﬂuorescence
produced when PicoGreen dye is excited by UV light while bound to dsDNA. After
incubation periods, the well plates were gently rinsed once with sterile PBS. Then,
1 mL of ultra-pure sterile water added and kept at 80 C until quantiﬁcation. For
the quantiﬁcation, samples were defrosted at room temperature and the content
was transferred to eppendorfs. 100 mL of TriseEDTA buffer were transferred into a
white opaque 96-well plate. Samples were vortexed and 28.8 mL of each plus 71.2 mL
of PicoGreen solutionwere added to thewells. After 10min of incubation in the dark,
the plate was read in a microplate reader using an excitation wavelength of 485 nm
and emission wavelength of 528 nm. A standard curve was created by varying the
concentration of standard dsDNA standard from 0 to 2 mg.mL1, and triplicates
dsDNA values of the samples were read off from the standard graph. At least six
specimens were measured per each sample. The experiment was repeated once
more.
Cell proliferation was calculated by assuming as 1-fold the difference between
the dsDNA content at 20 h and 4 days in TCPS.2.3.6. ALP quantiﬁcation
ALP activity was quantiﬁed in the same samples used for dsDNA quantiﬁca-
tion. The activity of ALP is typically evaluated using the p-nitrophenol assay.
Paranitrophenyl phosphate, which is colorless, is hydrolyzed by alkaline phos-
phatase enzyme at pH 9.8 and 37 C to form free p-nitrophenol, which is
yellowish. The reaction was stopped by addition of NaOH and the absorbance read
at 405 nm. Brieﬂy, in each well 20 ml of each sample, previously vortexed, were
mixed with 60 ml of the substrate solution which is 0.2% (w/v) p-nitrophenyl
phosphate (SigmaeAldrich) prepared in a substrate buffer of 1 M diethanolamine
(SigmaeAldrich) at pH 9.8. The plate was then incubated in the dark for 45 min at
37 C. After the incubation period, 80 ml stop solution, which is composed by 2 M
NaOH (Panreac) plus 0.2 mM EDTA (SigmaeAldrich), was added to each well.
Standards were prepared with 10 mmol mL1 p-nitrophenol (pNP, Sigma, USA)
solution, to obtain a standard curve covering the range 0e0.2 M. Triplicates of
each sample and the standard were made. Finally, absorbance was read at 405 nm
in a microplate reader (Bio-Tek, Synergie HT) and sample concentrations in
triplicate were read off from the standard curve. The ALP concentrations were
normalized against the dsDNA concentrations of the same samples to determine
the cellular ALP activity.2.3.7. Flow cytometry
Flow cytometry was performed using anti-human CD90 APC (BD Pharmin-
gen™), anti-human CD105 FITC (BioRad), anti-human CD73 PE (BD Pharmingen™),
anti-human CD34 PE (BD Pharmingen™), anti-human CD31 APC (R&D Systems),
anti-human CD45 FTIC (BD Pharmingen™). Experiments were performed using
hASCs in passages between 5 and 6, before the seeding and after 4 days in culture on
the unmodiﬁed and modiﬁed surfaces.
Cells were trypsinized, counted and re-suspended in PBS with 2% (w/v)
bovine serum albumin (BSA) (Sigma) with a concentration of 2  105 cells/100 mL
and incubated with the antibodies at the concentration advised by the manu-
facturers. After incubation for 20 min at room temperature, protected from light,
cells were washed with PBS/BSA, re-suspended in PBS with 1% formaldehyde
(Sigma) and analyzed in a BD FACSCalibur™ ﬂow cytometer (BD Biosciences).
Cells of interest were gated in a forward vs. side scatter dot plot with a linear
scale. Isotype controls were made to discern non-speciﬁc from speciﬁc staining.
A minimum of 10,000 gated events were acquired and labeled cells were
quantiﬁed.
CD's variations were calculated relatively to their initial content in the hASCs
before seeding, for each sample. The calculation consisted in the difference be-
tween the percentages of each CD before and after 4 days in culture, for both
donors.2.4. Statistical analysis
First, it was veriﬁed with ShapiroeWilk test that most of the data did not passed
the normality test. All data was statistically analyzed by using non-parametric tests.
The unpaired one-tailed t-test with Welch's correction for non-parametric data was
used (p  0.05).
Spearman's Correlation was computed to assess the relationship between
several variable pairs to verify the existence of any positive or negative monotonic
correlation, using Graphpad Prism.
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3.1. Nanocoatings assembling
LbL assembling is a versatile and simple technique in the
context of cellesurface interactions design. This work has focused
on the development of cell instructive multilayers prepared by
combining distinct polysaccharides with proteins derived from0
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(Chi; þ1), as unsulfated ones; and k-, i-, and l-carrageenan (k, i, l-
Car; 1, 2, 3 respectively), as sulfated ones; along with heparin
(Hep; 3), as control e Scheme 1c. We hypothesize that the
chemical diversity of such PEs will allow tuning of the incorpo-
ration of bioactive factors from PL and, consequently, cellular
response.
The assembling of the PE/PL combinations was monitored using
QCM-D e Fig. 1a. It was observed that proteins from PL (10% v/v)
adsorbed independently of the PE charge or SD. Alg/PL, Chi/PL, kPL,
i/PL, lPL and Hep/PL nanocoatings, with 6 bilayers, were assembled
on silicon wafers. The mean thicknesses were measured by ellips-
ometry on dried samples e Fig. 1b. These varied between 30 and
50 nm, being similar among most of the conditions. The nano-
coatings produced with the positively charged PE, Chi, were shown
to be the thickest (p < 0.05) though similar to the one containing i/
PL. A large fraction of the PL proteins are negatively charged in a pH
range of 5.5e6 (as opposed to several GFs), which may explain the
higher thickness of Chi/PL nanocoatings. The multilayers were
amenable to being produced using negatively charged PEs as well.
Electrostatic interactions should contribute signiﬁcantly to the
stabilization of the multilayers, although other kinds of interactions
could participate in the LbL construction, such as, hydrophobic or
hydrogen bonds [38].
Total protein quantiﬁcation indicated that the proﬁle of protein
adsorptionmay be affected by PL concentratione Fig. 2a, b.With PL
10% (v/v), Chi and k could adsorb a higher content, as compared to
all other PEs (p < 0.05). Increasing the PL concentration, from 10% to
100%, highly increased the content of protein (p < 0.005; 3e5 fold)
on the unsulfated and on the more sulfated PEs (SD ¼ 3).
The binding of speciﬁc GFs, namely PDGF, FGFb and VEGF, was
investigated e see Fig. 2 c, d and e, respectively. The type of PE
revealed to have a huge impact in the total content of PL, as well as,
in the incorporation of the GFs. Even though sulfate groups areFig. 2. Quantiﬁcation of PL, VEGF, bFGF and PDGF adsorption onto different PEs layers. Total p
v). Content of GF adsorbed: c) PDGF, d) bFGF, e) VEGF. d) Density of GFs in the formed pro
statistically similar (with p > 0.05) are indicated with exception of d) where # represents
samples. In a) and b), x and * mean signiﬁcant difference between the total protein adsorptio
of f) can be consulted in Table S1. Data represented as mean ± SEM; n ¼ 6.appropriated to bind GF through electrostatic interaction, higher
SDmay not imply higher adsorption. Actually, the densities of VEGF
and FGFb did not correlate with the SD, nor with the total protein
adsorbed e Table S2. Moreover, the adsorption of PDGF tended to
decrease with the increase of the SD. Consequently the VEGF/PDGF
and FGFb/PDGF ratios were increased with the increase of the SD e
Table S2. Nevertheless, when comparing with the unsulfated, the
sulfated ones and Hep could achieve high levels of GFs adsorption.
But, interestingly, they have shown different adsorption abilities.
Hep could adsorb a high content of VEGF, while kwas more prompt
for a high PDGF and intermediate VEGF adsorption. On the other
hand, iCar achieved the highest levels of VEGF, FGFb and PDGF
adsorption. Contrarily, l Car has not shown the ability to highly
adsorb any of the quantiﬁed GFs.
In general, the total content of protein adsorbed did not allow
predicting of the respective content of GFs incorporated. In fact,
several signiﬁcant differences were detected in the PL layer rela-
tively to its local density of VEGF, FGF and PDGF e see Fig. 2 f and
Table S1. The PEs showed different patterns for the incorporation
of GFs. This highlights the importance of the initial surface
chemistry regarding the interaction of platelets derivatives with
biomaterials.
Overall, the ratios of GFs can be varied with the PE, as well with
the SD. This may represent a simple way of adjusting or improving
the cell instructive cues of 2D/3D biomaterials, according with the
target applications.
3.2. Cell morphology
Stem cell cytoskeleton organization has been correlated with
cell fate commitment, besides being informative about cell senes-
cence [39e42]. The proliferation rate of stem cells decays with
increasing number of passages, and ultimately cells reach a se-
nescent state. In the case of mesenchymal stem cells, senescence isrotein adsorbed accordingly with initial PL concentration: a) PL 10%(v/v), b) PL 100% (v/
tein-layer. All combinations of pairs of samples were compared and only the pairs not
the only signiﬁcant differences (p < 0.05): i is signiﬁcantly different to all the other
n with PL 10% and PL 100% with p(<0.05) or p(<0.005), respectively. Statistical analysis
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expression of surface markers and decreased differentiation po-
tential [43].
The potential of the developed nanocoatings to induce any
signiﬁcant changes on the morphology was assessed by charac-
terization of thewidth and lengthe Fig. S1, cell aspect ratio (length/
width) and mean area eFig. 4, after 20 h of culture e Fig. 3a. In our
study, hASCs (P6-7) cultured on TCPS were approximately 50 mm
wide e Fig. S1 a, b. The presence of SO3H end groups reduced cell
width in comparison with TCPS. Introducing PL on the nano-
coatings further decreased the cell width for almost half of what
was measured in TCPS. Correlation's analysis suggested that there
was a moderate correlation between FGF/VEGF and FGF/PDGF ra-
tios with cell width e Table S2. Among the sulfated-PL nano-
coatings, cell width tended to reduce when the ratio of FGF/VEGFTCPS 
A
lg
 
κC
ar
C
hi
ιC
ar
 
λC
ar
 
H
ep
 
100 μm 
100 μm 100 μm 
100 μm 100 μm 
100 μm 100 μm 
100 μm 100 μm 
100 μm 100 μm 
100 μm 100 μm 
w/o PL w/ PL
20 hoursa
Fig. 3. a) hASCs morphology after 20 h and b) 4 days in culture, in presence of 10% of serum.
this ﬁgure legend, the reader is referred to the web version of this article.)was increased, when FGF/PDGF was decreased and VEGF density
was lowered e Table S2.
On the other hand, hASCs length tended to increase with the
presence of SO3H e Fig. S1 c, d. Comparing these with the respec-
tive surfaces with PL, its presence did not signiﬁcantly alter cell
length, with exception of l/PL and Hep/PL nanocoatings where it
was a slightly decreased (p < 0.05). The increased cohesion be-
tween cells with the incorporation of PL may have masked the tips
of the ﬁlopodia and/or actually reduced cell length on those two
samples. Nevertheless, Spearman's correlation pointed out that cell
length tended very strongly to increase with increase of PDGF and
PL, which simultaneously, represented a decrease in VEGF/PDGF
and FGF/PDGF ratios.
All the width and length variations induced by the presence of
the multilayers led to a huge reduction on cell mean area by 1/4 toTCPS 
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S.M. Oliveira et al. / Biomaterials 48 (2015) 56e65621/2 from the initial 4000 mm2 on TCPS. However, the cytoskeleton
was elongated, representing an increased aspect ratio (length/
width) e Fig. 4 a, b.
Overall, the presence of SO3H on the surface made the cells
achieve a slightly higher length and smaller width that further
diminished when PL was incorporated. Consequently, cell aspect
ratio was increased to 6e8 on the multilayers containing PLe Fig. 4
c. The developed nanocoatings reverted the enlarged morphology
observed on TCPS.
3.3. Cell adhesion, proliferation and ALP activity
In order to verify the bioactive ability of the developed multi-
layers, their effect over hASCs adhesion and proliferation was
assessed in short-term cultures e Fig. 5.
48-well culture plates were modiﬁed with PE, and PE/PL mul-
tilayers with 6 bilayers. Cells were seeded at an initial density of
5000 cells.cm2 in the presence and absence of serum proteins.
In the absence of both PL and medium serum, cell adhesion was
very limited and almost no differences were detected between
TCPS and the PEs coatingse Fig. 5 a. The presence of PL signiﬁcantly
increased cell adhesion in the cases of k/PL and i/PL, by 5 and 8-fold,
respectively, as compared to TCPS (p < 0.05). This suggested that
those might be the nanocoatings which are richer in cell-adhesive
moieties, or that cell adhesion could have been mediated by in-
teractions between surface PDGF and cell PDGF receptors. When
serum was included in the culture media, cell attachment was not
as affected by the presence or absence of PL (p > 0.05) e Fig. 5 b.
However, the surfaces containing PL, namely i/PL and Hep/PL,
allowed for a higher cell attachment than TCPS (p < 0.05).
The proliferation rate of hASCs usually decreases with
increasing passage number. PL media supplementation has been
reported to enhance cell proliferation and even refresh high pas-
sage cells [44,45]. We believe that the expansion of high passage
hASCs onto the PL-multilayers might be a way to increase the
proliferation ratio and avoid/delay senescence. hASCs (passage
5e6) were, therefore, cultured on the developed nanocoatings.
dsDNA quantiﬁcation and proliferation ratios upon 4 days of culture
are shown in Fig. 5 c and Fig. 6 a, respectively. Overall, hASCs were
able to proliferate on all the surfaces, and to reach over-conﬂuence
on the coatings withmore SO3H groups and PLe Fig. 3 b. Those also
allowed a higher hASCs proliferation as compared with TCPS.
Regarding the multilayers, i/PL and Hep/PL have shown the highestability to improve cells proliferation (p < 0.05; ~2 fold relatively to
TCPS) e Fig. 6 a. Chi/PL nanocoatings were the only samples whose
proliferation was impaired (p < 0.05). This suggests that solely Chi,
or a positively charged PE, may not be adequate to attract bioactive
proteins suitable to promote cell proliferation. Moreover, since Chi
is uncharged during the culture, it may not ensure sufﬁcient sta-
bilization, or an adequate conformation of the adsorbed bioactive
proteins.
The mitogenic induction can be accomplished by supplement-
ing culture medium with GFs, such as VEGF [46], FGF [47], PDGF
[48e50] and EGF [47], in a dose-dependent manner. Those mito-
genic GFs can be found in PL, which is already established as me-
dium supplement, to improve cell proliferation. Its mitogenic
potential has been correlated with the concentration of PDGF [48].
As shown in the previous section, depending on the PE, the per-
centage of the mitogenic GFs cannot be assumed as equivalent to
the total content of proteins adsorbed. Moreover, the sole ability of
the PE to attract a speciﬁc GF may not be a good proliferation
predictor factor if the PE itself improves cell proliferation. For
example, proliferation on Hep surfaces was higher when compared
with the other coatings without PL. The ability of Hep to improve
cell proliferation has also been reported elsewhere [51,52]. By
verifying the existence of correlations between GF surface density
and cell proliferation, it was possible to detect a moderately posi-
tive correlation with VEGF and FGF. A higher ability of the PE to
adsorb VEGF or FGF may be a moderate indication of a higher cell
proliferation e Table S2. In addition, the morphological features
showed to be correlated with proliferation. Cell proliferation ten-
ded to be higher on cells with higher cell aspect ratios and with
decreased widths. In general, the culture of hASCs on these PL-
multilayers has reverted the enlarged morphology, which is a
senescence-associated feature, and has increased cell proliferation.
In vitro, alkaline phosphatase (ALP) is highly expressed in early
osteogenesis, and is also considered a universal pluripotent marker
for all types of pluripotent stem cells including embryonic stem
cells, embryonic germ cells and induced pluripotent stem cells
[53,54]. In hASCs, a signiﬁcant increase in ALP activity during
normal medium conditions suggests a cell-commitment to the
osteoblastic lineage or cell aging [55]. Therefore, when solely
expanding multipotent stem cells, a highly signiﬁcant ALP increase
might be unwelcome since it may compromise stemness. The ALP
activity per lysed cell was quantiﬁed after 20 h and 4 days in culture
e see Fig. 6 b. ALP signiﬁcantly increased (p < 0.05) with increasing
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S.M. Oliveira et al. / Biomaterials 48 (2015) 56e65 63culture time although, at different extents depending on the
coating. On k, l, i/PL, l/PL and the Hep/PL nanocoatings, ALP activity
increase was much lower than TCPS (p < 0.05). The variations in
ALP activity, upon 4 days in culture, were not correlated with cell
content, proliferation, GFs and PL content, nor with the assessed
morphological features e see Table S2. Nevertheless, there was a
moderate positive correlation between the samples with and
without PL, which also denotes the importance of the surface
chemistry. One cannot exclude that the PE coatings may haveadsorb similar proteins from media serum, although in lower
concentration. The overall variations in ALPmay be relatedwith the
presence of other proteins, or proteins ratios not contemplated in
the analysis. ALP activity has been shown to vary with the ratio of
the GFs used as medium supplement. For instance, FGFb has been
reported to decrease ALP activity when used as media supplement,
as opposed to VEGF [56]. When FGFb was combined with VEGF, the
ALP activity reached values within the range of VEGF and FGFb
alone but, lower than the increased value when cultured only with
VEGF [56]. Herein, as mentioned above, there was no correlation
between FGF/VEGF ratio and the ALP variations. This suggests that
other important factors, not contemplated in the analysis, may have
been decisive for hASCs behavior.
Different combinations of PE and PL could be used to tune the
ALP activity and proliferation and translate different osteogenic
potentials in longer-term cultures.
3.4. hASCs phenotype
Cultured population of hASCs are strongly characterized by
being positive to CD105, CD90 and CD73 regardless of their passage
or time in culture and weak or negative for CD34 and CD31 [57,58].
Within lower passages the multipotency and the proliferation
capability is not altered. However, the cell phenotype changes: both
CD34 and CD31 expression declines, being accompanied by an in-
crease of CD90 and CD105 [57,58]. Suga et al. [59] reported that the
expression of CD34 in hASCs can be reversed. hASCs lost CD34
expression upon culturing with DMEM but regained expression
after being cultured with endothelial basal medium [59]. The same
authors also suggested that the loss of CD34 may be related with
the physiological process of commitment and/or differentiation
from immature status into speciﬁc lineages such as adipose, bone
and smooth muscle [59]. The hASCs phenotype was characterized
before seeding (P5eP6) and after 4 days in culture, on some of the
multilayers that showed improved cell proliferation: i/PL and k/PL
using TPCS and i as controls. Results in Table 1 are shown as the
variation on the percentage of each CD with the culture on each
respective surface, in relation to the original phenotype before
seeding.
TCPS showed the common trend of decreasing CD34, CD31 and
CD45 positive cells while increasing CD105 and CD73 positive cells.
On the other hand, SO3H and PL interfered with the percentage of
CD31 and CD34 positive cell. A plausible reason for such variation
would be the binding of CD31/CD34 positive cells (positive cells for
VEGF receptor) mediated by VEGF or other speciﬁc GFs that had
been incorporated.
The results suggest less sulfated nanocoatings asmore beneﬁcial
for cell proliferation applications. Whereas higher sulfated coatings
might be more suitable for differentiation purposes or, more spe-
ciﬁcally, for bone and vascular engineering, since they present
higher FGF/PDGF and VEGF/PDGF ratios.
4. Conclusions
hASCs are anchorage-dependent cells and the interactions with
the biomaterial surface dictate their behavior and fate. PL is a cost-
effective source of several autologous bioactive proteins, e.g. GFs.
Herein, we show the preparation of cell instructive multilayers by
assembling PL with several PEs using LbL.
The PE nature and the SD, are important features that have
inﬂuenced the adsorption of PL, VEGF, FGFb and PDGF. Intermediate
sulfated polysaccharides weremore prompt for high FGFb, VEGF and
PDGF incorporation. The low sulfated polysaccharides could adsorb
high PDGFand intermediate VEGF,whileHep showedonlyhighVEGF
adsorption. Consequently, by increasing the SD, the VEGF/PDGF and
TC
PS κ ι λ Hep κ/P
L ι/PL λ/P
L
He
p/P
L
Ch
i/P
L
Al
g/P
L
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
20 hours
4 days
1.
0
0.
8 0
.6 0.
9 1
.8
1.
1
0.
4
1.
7 1
.8
1.
5
2.
2
ds
D
N
A
 (μ
g 
cm
-2
)
TC
PS κ ι λ Hep Ch
i
Al
g
κ/P
L ι/PL λ/P
L
He
p/P
L
Ch
i/P
L
Al
g/P
L
0.00
0.05
0.10
0.15
0.20
0.25 20 hours
4 days
*
*
*
*
* *
*
*
* *
*
*
*
#
#
# #
#
&
&
A
LP
 a
ct
iv
ity
 (m
m
ol
 A
LP
/d
sD
N
A
)
Proliferation ALP activitya b
Fig. 6. hASCs proliferation ratios and ALP activity after 20 h and after 4 days of culture on the nanocoatings. a) Each set of superimposed bars show the dsDNA content at 20 h and 4
days with the proliferation ratios (relative to TCPS) indicated in the bars inset; b) Each set of superimposed bars corresponds to the ALP/cell after 20 h and 4 days in culture. All the
statistical signiﬁcances are identiﬁed: bars refer to the data of 4 days in culture, * (ALP varied from 20 h to 4 days), # (ALP at 4 days is different from ALP on TCPS 4 days), & (ALP on
sample PE1/PL is different to PE1, after 4 days in culture); (p  0.05; n ¼ 10; 2 donors). Data presented as mean ± SEM.
Table 1
Flow cytometry assessment of the phenotype changes between P5-6 to P6-7 when
cultured on the nanocoatings or TCPS for 4 days. Table shows the CD (Cluster of
Differentiation) variation comparing with the phenotype before seeding
(mean ± SD; 2 donors).
TCPS i i/PL k/PL
CD105 0.0 ± 0.1 1.6 ± 0.5 1.3 ± 0.9 1.2 ± 0.0
CD73 0.2 ± 0.1 0.3 ± 0.4 0.4 ± 0.8 1.0 ± 0.4
CD90 0.0 ± 0.1 0.2 ± 0.2 0.2 ± 0.2 0.8 ± 0.2
CD45 0.4 ± 0.2 0.2 ± 0.7 0.6 ± 0.9 2.2 ± 0.6
CD34 0.3 ± 0.1 1.0 ± 2.4 0.5 ± 1.7 1.3 ± 0.2
CD31 0.2 ± 0.9 1.9 ± 2.4 1.4 ± 2.9 0.2 ± 0.4
S.M. Oliveira et al. / Biomaterials 48 (2015) 56e6564FGF/PDGF ratios tended to increase. Overall, the biomimetic sulfated
PL-multilayers were shown to be efﬁcient in the promotion of
morphological changes, serum-free cell adhesion and cell prolifera-
tion. The results highlight the importance of the initial surface
chemistry regarding the incorporation of platelets derivatives into
biomaterials. For instance, the more sulfated PL nanocoatings might
be more adequate for vascular or differentiation purposes since they
permit a lower FGFb and PDGF incorporation than the less sulfated
ones. The speciﬁc interactions of the PL containing coatings with
endothelial cells will be investigated in future work.
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